Alvotech Ordinary Shares (ALVO) is a publicly traded Healthcare sector company. As of September 10, 2026, ALVO trades at $5.22 with a market cap of $1.85B and a P/E ratio of 0.00. ALVO moved +0.39% today. Year to date, ALVO is +1.56%; over the trailing twelve months it is -35.76%. Its 52-week range spans $2.94 to $13.46. Analyst consensus is buy with an average price target of $5.67. Rallies surfaces ALVO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
3 analysts cover ALVO: 0 strong buy, 2 buy, 0 hold, 1 sell, and 0 strong sell. The consensus rating is buy. The average price target is $5.67.
| Metric | Value |
|---|---|
| Price | $5.22 |
| Market Cap | $1.85B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $13.46 |
| 52-Week Low | $2.94 |
| Volume | 509.13K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
3 analysts cover ALVO: 0 strong buy, 2 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.67.